Effects of a phosphodiesterase type 5 inhibitor (SILDENAFIL) evaluated by 24-hour blood pressure monitoring and exercise capacity in heart transplanted patients. A double-blind, placebo-controlled, cross-over, randomized study. Preliminary results

✍ Scribed by G.V. Guimaraes; V.M. d’Avila; P.V. Pires; F.D. Cruz; N.A. Stolf; P.R. Chizzola; E.A. Bocchi

• Book ID: 116518523
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 63 KB
• Volume: 24
• Category: Article
• ISSN: 1557-3117
• DOI: 10.1016/j.healun.2004.11.246